Type 2 Diabetes Trial, Recruiting NCT06908486 Sponsor: University of Sydney Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06908486
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with Type 2 diabetes
  • People who have persistent pain, meaning pain that is present on more days than not for at least 3 months
  • People whose average pain severity scores 3 or higher on a standard pain measurement tool called the Brief Pain Inventory
  • People who are fluent in English
  • People who have access to the internet and are able to use a computer for a three-month period

Who may not be able to join:

  • People who are under 18 years of age
  • People who do not have a diagnosis of Type 2 diabetes
  • People who do not have persistent pain
  • People who are not fluent in English
  • People who do not have access to the internet or are unable to use a computer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Louise Sharpe, University of Sydney

Phone: +61449610131

Australian sites

University of Sydney, Camperdown, New South Wales
+61449610131

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Sydney
Registry
ClinicalTrials.gov
Start date
15 April 2025
Est. completion
15 July 2025

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Pain severity; Pain interference

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov